Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zhou, J.
Right arrow Articles by Ríos, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zhou, J.
Right arrow Articles by Ríos, E.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

J Biol Chem, Vol. 273, Issue 39, 25503-25509, September 25, 1998


Molecular Cloning and Functional Expression of a Skeletal Muscle Dihydropyridine Receptor from Rana catesbeiana*

Jingsong ZhouDagger §, Leanne Cribbs, Jianxun YiDagger , Roman ShirokovDagger , Edward Perez-Reyes, and Eduardo RíosDagger parallel

From the Dagger  Department of Molecular Biophysics and Physiology, Rush University, Chicago, Illinois 60612 and  Department of Physiology, Loyola University, Maywood, Illinois 60153

    ABSTRACT
Top
Abstract
Introduction
Procedures
Results
Discussion
References

In skeletal muscle the dihydropyridine receptor is the voltage sensor for excitation-contraction coupling and an L-type Ca2+ channel. We cloned a dihydropyridine receptor (named Fgalpha 1S) from frog skeletal muscle, where excitation-contraction coupling has been studied most extensively. Fgalpha 1S contains 5600 base pairs coding for 1688 amino acids. It is highly homologous with, and of the same length as, the C-truncated form predominant in rabbit muscle. The primary sequence has every feature needed to be an L-type Ca2+ channel and a skeletal-type voltage sensor. Currents expressed in tsA201 cells had rapid activation (5-10 ms half-time) and Ca2+-dependent inactivation. Although functional expression of the full Fgalpha 1S was difficult, the chimera consisting of Fgalpha 1S domain I in the rabbit cardiac Ca channel had high expression and a rapidly activating current. The slow native activation is therefore not determined solely by the alpha 1 subunit sequence. Its Ca2+-dependent inactivation strengthens the notion that in rabbit skeletal muscle this capability is inhibited by a C-terminal stretch (Adams, B., and Tanabe, T. (1997) J. Gen. Physiol. 110, 379-389). This molecule constitutes a new tool for studies of excitation-contraction coupling, gating, modulation, and gene expression.

    INTRODUCTION
Top
Abstract
Introduction
Procedures
Results
Discussion
References

In EC1 coupling an action potential activates DHP receptors in the transverse tubular membrane, which somehow open ryanodine receptors in the sarcoplasmic reticulum to release Ca2+ and initiate muscle contraction. The skeletal muscle DHPr is a slowly activating L-type Ca2+ channel (2) that also controls Ca2+ release, working as a voltage sensor (3, 4). How DHPrs interact with ryanodine receptors during EC coupling is still not clear. Most experiments on EC coupling have been done in frog skeletal muscle fibers, although the cDNAs of skeletal muscle DHPr have been cloned from rabbit (5), fish (carp) (6), and human (7). Functional differences exist between frog and mammalian skeletal muscle DHPrs. Seeking additional insights into the molecular basis of skeletal muscle EC coupling, we cloned and expressed a skeletal muscle DHPr from a frog.

The frog DHPr (Fgalpha 1S) was cloned from mRNA of skeletal muscle of Rana catesbeiana by combining RT-PCR with construction and screening of a cDNA library. The molecule has high homology with other DHPrs at transmembrane domains, voltage sensors (5), pore regions (8), and DHP binding sites (9). Despite those conserved features, Fgalpha 1S has also several differences with known DHPrs.

The cloned rabbit skeletal muscle L-type Ca channel has been expressed in dysgenic myotubes (4) and in Xenopus oocytes (10). However, functional expression of this channel in mammalian cell lines has been difficult (11-14). In our hands, the functional expression of Fgalpha 1S also occurred infrequently. In contrast, a chimera (named alpha 1C-FSDI) of domain I of Fgalpha 1S in a rabbit cardiac background was expressed easily and at high levels.

    EXPERIMENTAL PROCEDURES
Top
Abstract
Introduction
Procedures
Results
Discussion
References

RNA Preparation-- Total RNA samples were isolated from the liver, cardiac, and skeletal muscle of a frog by the acid guanidinium-phenol-chloroform method (15). Poly(A)+ RNA was purified from the total RNA by using the Mini-oligo(dT) cellulose spin kit (5 Prime right-arrow 3 Prime, Inc., Boulder, CO).

cDNA Cloning by RT-PCR-- Total RNA harvested from frog skeletal muscle was reverse transcribed using random primers. Based on the conserved amino acid sequences of known DHP receptors, two pairs of degenerate primers (C5/C6 and C12/J3) were synthesized for amplifying a cDNA segment (segment 7) between IIIS6 and IVS6 and a segment (segment 6) between IS1 and IIS3 of the channel molecule. Primer C5 (5'-CGCGGAATTC TT(T,C) ATG ATG AA(C,T) AT(T,C,A) TT(T,C) GT-3', with base degeneracy represented in parentheses) had an EcoRI restriction site at the 5' end (bold) fused to the DNA sequence of FMMNIFV in IIIS6. Primer C6 (5'-CGG CGG ATCC A NAG CAT(A,G)TA (A,G)AA (A,G)CT (A,G,T)AT (A,G)AA-3') had a BamHI site at the beginning fused to the cDNA sequence of FISFYML in IVS6. Primers C12 (5'-AT(A,C,T) GTN GA(A,G) TGG AA(G,A) CCN TT-3') and J3 (5'-AA (A,G)CA (A,G)TC (A,G)AA NC(G,T) (A,G)TT (A,G)AA-3') were derived from the conserved amino acid sequences IVEWKPF at the beginning of domain IS1 and FNRFDCF in domain IIS3, respectively. Based on the cDNA sequences of cloned frog cDNA segments 6 and 7, nondegenerate primers (J4 and J5) were designed to amplify the cDNA (segment 9) between domains II and IV. Primer J4 (5'-GCC CTT GGT TTC CAG TCA TAT TTC-3') corresponds to the amino acid sequence ALGFQSYF in IIS2, and J5 (5'-CAT ACC AAG GCT GAT GGT GTT CAG-3') presents the cDNA sequence of LNTISLGM in IVS1. Control reactions were performed in the absence of reverse transcriptase to rule out possible contamination by genomic DNA. First-strand cDNA synthesis kits were from either Boehringer Mannheim or Pharmacia Biotech, Inc. PCR products were subcloned into pGEM-T vectors (Promega, Madison, WI).

cDNA Cloning by Constructing and Screening a Frog Skeletal Muscle cDNA Library-- Because there are no conserved sequences at both C and N termini of known Ca channels, no gene-specific primers could be designed for RT-PCR. A frog skeletal muscle cDNA library was constructed instead, and the probes derived from RT-PCR clones (segments 6 and 7) were used to screen it and to obtain both 5' and 3' cDNAs. Double-stranded cDNA was synthesized using the Superscript Choice system for cDNA synthesis (Life Technologies, Inc.). The size-fractionated cDNA (>1 kb) was ligated into the lambda ZAP Express vector (Stratagene, La Jolla, CA). The recombinant phage vectors packaged with a protein coat (Gigapack II Gold, Stratagene) were used to infect XL1-Blue-MRF' bacteria (Stratagene) to construct the library. Positive clones pBK/5-13 (covering the 5' untranslated region), pBK/5-8, pBK/5-10 (covering the 3' untranslated region), and pBK/5-5 were obtained by screening the library.

DNA Sequencing and Analysis-- All cDNA clones were sequenced using the Sequenase 2.0 DNA sequencing kit (Amersham Corp.) and the ABI PRISM dye terminator cycle sequencing ready reaction kit (Perkin-Elmer). Sequence similarity searches of GenBankTM were performed with PCGENE (IntelliGenetics, Mountain View, CA) and DNASIS (Hitachi-Software, South San Francisco, CA).

Full-length Channel Construction-- Based on suitable restriction enzyme sites (Fig. 1), RT-PCR clones (segments 6 and 9) and the library clones (5-13, 5-5, and 5-8) were ligated to obtain the full-length molecule (Fgalpha 1S) in the mammalian expression vector pCR3.1 (Invitrogen, San Diego, CA).

Northern Blot Analysis-- Total RNA (20 µg) isolated from various frog tissues was separated on a 1% agarose-formaldehyde gel, transferred to Nytron BA-S-supported nitrocellulose membranes (Schleicher & Schuell), and cross-linked by baking for 2 h at 80 °C. The cDNA probe, including Fgalpha 1S nucleotides 4859-5600, was cut out from clone pBK/5-8 by NotI and XmnI digestion. The probe was radiolabeled with [alpha -32P]dCTP using random primers (Ready to Go DNA labeling beads, Pharmacia). The membrane was hybridized with the probe for 24 h at 42 °C in 6 × SSC, 50% formamide, 0.5% SDS, 100 µg/ml sheared salmon sperm DNA, and 5 × Denhardt's solution. The high-stringency wash was performed in 0.5 × SSC and 0.1% SDS at 60 °C. X-ray film (X-Omat AR, Eastman Kodak Co.) was exposed to the membrane at -80 °C. Glyceraldehyde-3-P dehydrogenase probes were also used for hybridization to estimate relative total RNA for each tissue.

Chimeric Channel Construction-- cDNA coding for domain I of rabbit cardiac channel (alpha 1C) at amino acid positions 165-422 was replaced by the corresponding cDNA segment from either Fgalpha 1S or rabbit skeletal muscle alpha 1S to obtain chimeras.2 The cDNA of alpha 1C has unique restriction sites, MfeI at nucleotide 689 of IS1 and BamHI at nucleotide 1456 of IS6. These unique sites also appear at the corresponding positions of Fgalpha 1S (491 and 1258, respectively). The cDNA (491-1258) was cut out from Fgalpha 1S and then ligated into MfeI and BamHI predigested pCR3/alpha 1C to produce the frog chimeric channel alpha 1C-FSDI. MfeI and BamHI sites are not present at the corresponding positions of domain I of rabbit alpha 1S, and the sites were introduced by PCR. The PCR product, which covers at 415-1185 of rabbit alpha 1S, was cut by MfeI and BamHI and then ligated into pCR3/alpha 1C to produce the rabbit chimeric channel alpha 1C-RSDI.

Transfection Procedure-- Large T-antigen-transformed human embryonic kidney cells (tsA201, a gift from Dr. M. M. Hosey, Northwestern University, Chicago, IL) were maintained in DMEM (Sigma) containing 10% fetal bovine serum (Biowhittaker, Walkersville, MD), 100 units/ml penicillin/streptomycin (Sigma) at 37 °C in 5% CO2. Rabbit skeletal muscle alpha 2/delta (in pMT2) was a gift from Dr. T. Tanabe (Tokyo Medical/Dental University, Tokyo, Japan). Rabbit cardiac alpha 1C was carried in pCR3 and rat brain beta 2a in pCMV. Seven micrograms of each cDNA (total <25 µg) were used for transfection by calcium phosphate precipitation (16). Expression efficiency was defined as the fraction of cells that had Ca2+ currents among those selected and patched.

Electrophysiological Studies-- Ionic currents were recorded by whole-cell patch clamp. Voltage clamping, pulse generation, and data acquisition were carried out with an Axopatch 200 A (Axon Instruments, Foster City, CA) and a 16-bit digital conversion card in a PC-compatible computer. The analog-to-digital and digital-to-analog routines were written by Ivan Stavrovsky in our laboratory. Pipettes were from borosilicate glass (Corning 7052; Garner Glass, Claremont, CA) heat polished to a tip outside diameter of 2-4 µm for a resistance of 2-4 MOmega . Ion currents were recorded with a pipette solution containing (in mM) 150 Cs+, 125 Asp-, 15 Cl-, 5 MgATP, 10 HEPES, and 10 EGTA, pH 7.6, adjusted by CsOH, and an external solution containing (in mM) 130 NaCl, 10 HEPES, and 10 Ca2+ or Ba2+, pH 7.3. Experiments were performed at 20-23 °C. Single, nonclustered cells were chosen for recording. Cells were pulsed from a holding potential of -90 mV. Asymmetric currents were obtained by subtraction of scaled control currents elicited with pulses from -130 to -100 mV.

    RESULTS
Top
Abstract
Introduction
Procedures
Results
Discussion
References

Sequence Alignments of RT-PCR and Library Clones-- The composite cDNA sequence of Fgalpha 1S was obtained by sequencing multiple overlapping clones. The sequence map of all clones is shown in Fig. 1. The 5'-end sequence, including an untranslated region, is present in the library clone 5-13. The 3'-end, including an untranslated region and a portion of the poly(A) tail, is covered by library clones 5-8 and 5-10. The cDNA sequences of the library clones (5-13, 5-5, 5-8, and 5-10) are equal to those of RT-PCR clones (segments 6, 7, and 9), with several single-base differences: 1) clone 5-13 has CGT780, whereas segment 6 and the full-length molecule have CGG780; both CGT and CGG encode arginine; 2) clones 5-13 and 5-5 have G876TA encoding valine, whereas segment 6 and the full-length cDNA have A876TA, encoding isoleucine; 3) clone 5-5 has T2151CT (serine), whereas segment 9 and the full-length cDNA have G2151CT (alanine) at this position; and 4) segment 7, clone 5-8, and the full-length cDNA have CTC4274, whereas clone 5-10 has CTT4274. Both CTC and CTT code for leucine. These single-base differences could be explained by polymorphism, also observed in alpha 1 cDNA clones from rabbit skeletal muscle (5).


View larger version (13K):
[in this window]
[in a new window]
 
Fig. 1.   Cloned cDNA segments. cDNA segments 6, 7, and #9 were obtained from RT-PCR and subcloned into pGEM-T. Clones 5-13, 5-5, 5-8, and 5-10 were obtained from the cDNA library in pBK(CMV) plasmid vectors. Sequences in the overlapping regions are identical, except for several base differences described under "Results." The restriction sites indicated on each clone were used for construction of the full-length Fgalpha 1S.

cDNA and Deduced Amino Acid Sequence of Fgalpha 1S-- The 5600-nucleotide cDNA sequence of Fgalpha 1S and its amino acid sequence are available (GenBankTM accession number AF037625). The polyadenylation signal sequence, AATAAA (17), is found between nucleotides 5554 and 5559, 16 nucleotides upstream of the poly(A) tail. Translation of the deduced channel protein (1688 amino acids) starts at nucleotide 303 with the first methionine and ends at nucleotide 5367, which is followed by the stop codon TGA. Transmembrane domains and pore regions were deduced from an alignment of Fgalpha 1S with rabbit cardiac (Rbalpha 1C) (18), skeletal (Rbalpha 1S) (5), and carp skeletal muscle (Cpalpha 1S) DHP receptors (6). Like other L-type Ca2+ channels, Fgalpha 1S has four putative transmembrane domains, but its C terminus is shorter than that of Rbalpha 1S and Cpalpha 1S. Table I lists the homology between different portions of Fgalpha 1S and rabbit and carp L-type Ca2+ channels. The homology is high with all L-type channels, but in every domain the highest homology is with Rbalpha 1S.

                              
View this table:
[in this window]
[in a new window]
 
Table I
Degrees of homology of Fgalpha 1S with other L-type Ca channels
Rbalpha 1C, rabbit cardiac channel; Rbalpha 1S, rabbit skeletal muscle channel; Cpalpha 1S, Carp skeletal muscle channel. Note the greater homology with the skeletal muscle channels and the high degree of homology with Rbalpha 1S in the critical II-III linker.

Conserved Structure of a Voltage Sensor-- The structural basis of the voltage sensitivity has been located at transmembrane segments S4 for voltage-gated K+, Na+, and Ca2+ channels (19-21). An alignment of the S4 segments of Fgalpha 1S with rabbit and carp channels (Fig. 2A) shows identical charges and almost perfect homology, consistent with the requirements for the voltage sensor of EC coupling and a voltage-operated ion channel.


View larger version (49K):
[in this window]
[in a new window]
 
Fig. 2.   Sequence alignment of Fgalpha 1S with other DHP receptors. Rbalpha 1C, alpha 1 subunit of rabbit cardiac channel; Rbalpha 1S, alpha 1 subunit of rabbit skeletal muscle channel, Cpalpha 1S, alpha 1 subunit of carp skeletal muscle channel. Dashes mark conserved amino acid residues in Rbalpha 1C. A, alignment of S4 in the four domains. B, putative pore regions. C, regions involved in DHP binding.

Conserved Structure for High-affinity Ca2+ Selection in Pore Regions-- The pore regions of ion channels have been localized to the linkers between segments S5 and S6 (22). Four glutamic acid residues at equivalent positions in pore regions have been demonstrated to determine the high-affinity Ca2+ binding in L-type channels (23), and other cloned high-voltage-activated Ca2+ channels also have these conserved glutamic acid residues at equivalent positions. The alignment of pore regions of Fgalpha 1S, rabbit, and carp channels is shown in Fig. 2B. Fgalpha 1S has conserved sequences in those regions, as well as the critical glutamic acid residues.

Conserved Structure for DHP Binding-- DHP binding affinity is an established criterion to distinguish L- and non-L-type Ca channels (24). The DHP binding site of L-type Ca channels appears to involve regions between transmembrane segments IIIS6 and IVS6, where residues Tyr1048, Ile1049, and Ile1052 in IIIS6 and Tyr1365, Met1366, Ile1372, and Ile1373 in IVS6 are critical (25). Fgalpha 1S has a sequence almost identical to other DHP receptors in the DHP binding regions, including all required residues at corresponding sites (Tyr1046, Ile1047, Ile1050, Tyr1352, Met1353, Ile1359, and Ile1360). The alignment of DHP binding regions of Fgalpha 1S with rabbit and carp DHP receptors is shown in Fig. 2C.

Conserved Structure for Skeletal Muscle-Type EC Coupling-- Unlike cardiac cells, in skeletal muscle Ca2+ release is triggered by DHPrs without requirement for entry of extracellular Ca2+ (26, 27). A crucial molecular determinant of skeletal muscle type EC coupling is at the intracellular loop between domains II and III of rabbit alpha 1S (28). The II-III loop of Fgalpha 1S has high (86%) homology with Rbalpha 1S (Table I), suggesting that Fgalpha 1S is a skeletal muscle-type voltage sensor.

PKA Phosphorylation Sites-- Skeletal muscle L-type Ca2+ channels are regulated by phosphorylation. In rat skeletal muscle fibers, both Ca2+ current and intramembranous charge movement are increased by PKA (29), whereas in frog fibers, only Ca2+ currents are increased by PKA (29) or cAMP (30). Serine 687, in the intracellular II-III loop of rabbit alpha 1S, is a major PKA phosphorylation site in vitro (31). Fgalpha 1S has no Ser or Thr at the corresponding position. In intact rabbit skeletal muscle myotubes other putative PKA sites have been located at Ser1757 and Ser1854 at the C terminus of the full-length channel (32). Fgalpha 1S, with a shorter C terminus, has no corresponding sites. By searching the derived amino acid sequence, we located a PKA phosphorylation site motif, RRXS (33), at the intracellular I-II loop of Fgalpha 1S (Ser424).

mRNA Distribution in Native Tissues-- To determine the tissue specificity of the cloned molecule, we carried out Northern blot analysis. Total RNA from frog heart, liver, and skeletal muscle tissues was hybridized with a cDNA probe derived from Fgalpha 1S, covering the 3'-untranslated region and the diverse sequence of the C terminus. Despite the differences in glyceraldehyde-3-P dehydrogenase signal between lanes, the ethidium bromide staining gel (data not shown) indicated that approximately the same amount of total RNA was loaded on each lane. The blot revealed a single RNA band in skeletal muscle (Fig. 3), consistent with the result found in mammalian skeletal muscle (34). There were no detectable transcripts in any of the other tissues, even using longer exposure times (data not shown).


View larger version (40K):
[in this window]
[in a new window]
 
Fig. 3.   Northern blot analysis of Fgalpha 1S. Total RNA from various tissues (20 µg each) of Rana catesbeiana was electrophoresed on an agarose-formaldehyde gel, blotted to a nitrocellulose membrane, and probed with Fgalpha 1S cDNA segment 4859-5600. A glyceraldehyde-3-P dehydrogenase (GAPDH) probe was used to evaluate relative RNA on the membrane for each tissue.

Expression of Full-length Fgalpha 1S-- tsA201 cells were chosen as a functional expression system for the cloned frog channel because HEK cells have no endogenous L-type Ca2+ currents (35), and large T antigen-transformed HEK cells (tsA201) express rabbit cardiac calcium channels efficiently (16).

In general, the functional expression of the wild-type clone was poor. Only in a few cells we obtained large, clearly extrinsic L-type Ca2+ currents. Nontransfected cells were patch clamped first as a control, and most had no detectable inward currents during depolarization. Three of 20 cells had small Ba2+ currents of 0.3 pA/pF. These currents were not sensitive to 5 µM extracellular Bay K (Table II), indicating the absence of endogenous L-type channels.

                              
View this table:
[in this window]
[in a new window]
 
Table II
Expression efficiency and current properties in cells transfected with Fgalpha 1S
One hundred forty cells were stable after whole-cell patching. The currents recorded in 15 of those were studied and included, either because they were >0.3 pA/pF (the native nontransfected cells) or because they had L-type characteristics (all others). IP is the normalized peak current, and tau 1/2 is the time to half-activation at the maximum of the current-voltage dependence.

Cells transfected with beta 2a or beta 2a plus alpha 2/delta were studied in search of L-type Ca2+ channel currents induced by transfection of auxiliary subunits. Five of 40 beta 2a-transfected cells patched had Bay K-sensitive currents. Fig. 4A shows Ba2+ currents from one of those. Peak and tail currents were increased three times by 5 µM Bay K (Table II). Two of 30 cells cotransfected with beta 2a plus alpha 2/delta had Ba2+ currents that were increased by Bay K. On average, these currents were somewhat greater than those of the beta 2a-transfected cells (Table II). In conclusion, extrinsic auxiliary subunits induce the expression of DHP-sensitive endogenous current of very low amplitude.


View larger version (23K):
[in this window]
[in a new window]
 
Fig. 4.   Ionic currents in cells transfected with Fgalpha 1S. A, Ba2+ currents in a cell transfected with beta 2a alone, with or without 5 µM Bay K in the bath. B1 and B2, Ba2+ currents in a Fgalpha 1S- plus beta 2a-transfected cell in reference (B1) or with Bay K (B2), elicited by pulses to voltages between -40 and +60 mV at 20 mV intervals. C1 and C2, Ca2+ (C1) and Ba2+ (C2) currents in a cell transfected with Fgalpha 1S plus beta 2a plus alpha 2delta . Cells were pulsed from a holding potential of -90 mV.

Fgalpha 1S was cotransfected into tsA201 cells in different combinations with cDNAs of other auxiliary subunits (beta 2a from rat brain and alpha 2delta from rabbit skeletal muscle). The frequency of cells with L-type currents was not increased compared with those transfected with auxiliary subunits only. However, the L-type current density was greater. Two of 20 Fgalpha 1S- plus beta 2a-transfected cells patched had peak Ba2+ currents at least two times larger than the maximum observed in the 40 cells transfected with beta 2a alone. Bay K increased the amplitude of peak and tail currents in these cells (Fig. 4B and Table II). Substitution of Ca2+ as current carrier reduced current amplitude substantially (data not shown).

Again, most of the 30 Fgalpha 1S plus beta 2a plus alpha 2/delta cells patched had no evidence of L-type currents. However, in three of them Ba2+ current density was >5-fold greater than the largest currents recorded in Fgalpha 1S plus beta 2a cells. As illustrated in Fig. 4, C1 and C2, and summarized in Table II, in those cells the current decreased ~2-fold when Ca2+ was substituted for Ba2+ as current carrier.

Half-times of activation of these currents (tau 1/2) are listed in Table II. Against our expectations activation of current in the cells transfected with Fgalpha 1S was much faster than in frog skeletal muscle, where tau 1/2 at 20 °C is ~70 ms at 0 mV (36).

Studies of Chimeric Channels-- Because functional expression of Fgalpha 1S was so infrequent, we carried out additional expression tests with a chimera of Fgalpha 1S and rabbit alpha 1C. In rabbit channels domain I determines the slow activation kinetics (37). Because the currents induced by the full Fgalpha 1S activated rapidly, neither domain I nor any other in the frog molecule was expected to make the activation of the chimeric construct slower. Still, we chose to splice domain I of Fgalpha 1S to rabbit alpha 1C (to make alpha 1C-FSDI), because a similar chimera with DI from Rbalpha 1S (named alpha 1C-RSDI) should have slower kinetics, thus providing overall control of the procedures. In all cases, beta 2a cDNA was cotransfected with the alpha 1 constructs.

The expression efficiency of alpha 1C was ~80%. Ca2+ and Ba2+ currents are illustrated in Fig. 5A. For IBa, the tau 1/2 at +30 mV was ~5 ms. Average tau 1/2 values are plotted versus voltage in Fig. 6.


View larger version (33K):
[in this window]
[in a new window]
 
Fig. 5.   Functional expression of alpha 1C and its chimeras. ICa and IBa in a cell transfected with rabbit wild-type alpha 1C (A), the rabbit chimera alpha 1C-RSDI (B), or the frog skeletal-rabbit cardiac alpha 1C-FSDI (C). All cells were co-transfected with beta 2a. Cells were held at -90 mV. Pulses were at 10-mV intervals in the range of -20 to +40 mV for ICa and -30 to +30 mV for IBa.


View larger version (13K):
[in this window]
[in a new window]
 
Fig. 6.   Kinetic properties of currents in cells transfected with alpha 1C or its chimeras. (A) activation kinetics. tau 1/2, determined in records such as those in Fig. 5 as the time to one-half of peak amplitude, averaged in seven cells for each type of molecule. Bars, ±S.E. bullet , FSDI; black-down-triangle , a1C; black-square, RSDI. B, inactivation kinetics. Ratio of ICa (open symbols) or IBa (filled symbols) at 100 ms, over peak current in the same record, calculated in records such as those in Figs. 4 (for Fgalpha 1S, triangles) and 5 (for alpha 1C, circles, or its frog chimera FSDI, squares) and averaged (numbers of cells listed in Table II).

Ca2+ and Ba2+ currents of a cell transfected with rabbit chimera alpha 1C-RSDI are shown in Fig. 5B. Average tau 1/2 values are plotted versus voltage in Fig. 6. tau 1/2 at +30 mV was ~13 ms, or two times that of alpha 1C. The currents obtained by expression of frog chimera alpha 1C-FSDI are shown in Fig. 5C. The expression efficiency of alpha 1C-FSDI was as high as that of rabbit alpha 1C, and Ca2+ and Ba2+ currents had a size similar to that of alpha 1C currents. The expressed chimeric current had L-type properties. Current amplitude was increased, and the voltage dependence of activation was shifted to the left by Ba2+. Unlike rabbit alpha 1S, and consistent with the currents obtained by transfection with the full clone, domain I of Fgalpha 1S did not slow down the current activation of the cardiac channel. tau 1/2 versus voltage is plotted in Fig. 6; the average tau 1/2 was 5.6 ms at +30 mV. The result strengthens the evidence that the cloned frog molecule is a Ca channel but one that in this expression system activates faster than the native current.

Current-dependent Inactivation of Expressed Channels-- L-type Ca2+ currents of cardiac muscle inactivate by a slow voltage-dependent mechanism and a faster, current-dependent mechanism. Initiation of the latter has been ascribed to Ca2+ binding to a stretch of the alpha 1C subunit, with similarities to an EF-hand (38), a view contested by Zhou et al. (39). Despite the discrepancy, there is agreement that the C terminus is largely responsible for ion-dependent inactivation. Moreover, this is a characteristic that distinguishes cardiac L-type from skeletal muscle channels, in which ion-dependent inactivation appears not to exist (1, 40). Two signature characteristics of this mechanism are a U-shaped voltage dependence and a much more marked effect when the current is carried by Ca2+ rather than Ba2+. We found both characteristics in the expressed current with both the full Fgalpha 1S and its chimera alpha 1C-FSDI. Fig. 6B plots the ratio between ionic current amplitude at 100 ms during a pulse and peak amplitude (reached usually at 20-30 ms during the pulse), as a function of pulse voltage. The filled symbols plot the results for IBa, a monotonically decreasing dependence, indicative of a lack of significant ion-dependent inactivation at 100 ms. The open symbols, representing the ICa results, show by contrast the characteristic U shape, indicative of current-dependent inactivation, equally marked when the alpha 1 subunit is cardiac (circles), frog skeletal (triangles), or the FSDI chimera (squares).

    DISCUSSION
Top
Abstract
Introduction
Procedures
Results
Discussion
References

We have obtained a cDNA from frog skeletal muscle and named it Fgalpha 1S. It has 5600 nucleotides and codes for a protein with 1688 amino acids, highly homologous with the DHP receptors, particularly rabbit skeletal muscle DHPr. As for all known L-type Ca2+ channels, the deduced protein has four putative transmembrane domains, a positively charged S4 in each domain, conserved Ca2+ channel pore regions, and putative DHP binding sites. The intracellular II-III loop, a molecular determinant of skeletal muscle-type EC coupling, is conserved very well in Fgalpha 1S. Additionally, Northern blot analysis showed that Fgalpha 1S is transcribed in skeletal muscle but not in heart or liver. For these reasons, the molecule qualifies as a skeletal muscle-specific DHPr.

Functional expression of this cDNA was possible, but only ~10% of the transfected cells that were studied had large L-type inward currents compared with 80% of the cells transfected with the frog and rabbit cardiac chimera. The reason for this low efficiency of expression, consistent with previous attempts to express the alpha 1S in mammalian cell lines (11-14), is unknown. Nevertheless, the good functional expression of the chimeric channel is further evidence that the cloned Fgalpha 1S encodes an L-type Ca2+ channel.

Surprisingly, the large L-type currents induced by transfection with Fgalpha 1S had fast activation, unlike that of the "slow" Ca2+ current of skeletal muscle, and a decay during 100 ms pulses with the characteristics of ion-dependent inactivation usually associated with cardiac ICa. Based on the existence of a fast and a slow phase in the activation of Ca currents (41), it has been proposed that there are two types of voltage-dependent Ca2+ channels in frog muscle. Fgalpha 1S might encode the "fast" Ca2+ channel. On the other hand, slowly activating Ca2+ currents of frog muscle can be switched to a fast activation mode by prior depolarization (42, 43). Therefore, the fast phase seen in the normal unconditioned current (and the currents induced here by Fgalpha 1S) may not correspond to a separate channel population but to a fraction of the slow channels showing fast gating kinetics in the steady state.

Because expression of the full Fgalpha 1S was seldom successful, we used part of its sequence in a chimera with a cDNA that expresses efficiently in tsA201 cells. We did achieve a much higher expression efficiency with the chimera, and the expressed currents were still cardiac like in their activation rates, as expected given the fast activation of the currents obtained with the full clone. Therefore, slow ICa activation kinetics, which for rabbit skeletal muscle is determined by domain I (37) and for carp skeletal muscle appears to be linked to domains III and IV (44), may for frog require other interactions that are lost when Fgalpha 1S is expressed in mammalian cells. Other protein molecules such as Ca2+ release channels, which appear to determine high current density (13), may be required for establishing native kinetics.

A related kinetic property of the expressed currents is the presence of ion-dependent inactivation, as revealed by voltage and ion dependence of the reduction of current after the peak. In skeletal muscle, ICa is not believed to undergo Ca2+-dependent inactivation (1, 40, 45). The currents obtained by expression of the Fgalpha 1S had a rapid phase of decay, to ~75% of their peak amplitude after 100 ms, that was clearly greater in Ca2+ than Ba2+. This decay therefore qualifies as Ca2+-dependent inactivation. Its presence is not inconsistent with the skeletal muscle origin of the channels because, as shown by Adams and Tanabe (1) on cardiac-skeletal chimeras expressed in HEK293 cells, the mechanism only requires the absence of a skeletal muscle-specific stretch in the primary sequence, rather than the presence of a cardiac-specific portion. These authors showed that deletion of the distal 211 residues in the (492-residue-long) C terminus of rabbit skeletal Rbalpha 1S restored Ca2+-dependent inactivation to the expressed currents. Fgalpha 1S, with the C-terminal 172 residues missing, has a structure close to that of the rabbit deletion mutant. The fact that it displays Ca2+-dependent inactivation supports the interpretation that the distal C-terminal segment is what prevents skeletal muscle channels from displaying this type of inactivation.

Despite its high homology with other DHP receptors, Fgalpha 1S has unique sequence features. The major PKA phosphorylation sites of rabbit alpha 1S are not conserved at corresponding positions of Fgalpha 1S. These structural differences may explain differences in regulation between mammalian and amphibian skeletal muscle DHPrs.

The C terminus of Fgalpha 1S (after IVS6) is 172 amino acid residues shorter than that of the corresponding full-length rabbit alpha 1S. Rabbit and rat skeletal alpha 1 subunits purified from T-tubule membrane and intact muscle cells in culture (46, 47) have a predominant form with an apparent molecular mass of 175 kDa (alpha 1175), which is truncated at the C terminus near residue 1690, and a minor form of 212 kDa, containing the complete amino acid sequence (48). Fgalpha 1S, with its 1688 amino acid residues, has nearly the same size as alpha 1175. Expression of a truncated rabbit cDNA with an even shorter C terminus (1662 amino acid residues, the same deletion mutant used in the work by Adams and Tanabe (1) mentioned earlier) fully restored both EC coupling and Ca current in dysgenic myotubes (2). This suggests that Fgalpha 1S may be sufficient to function in vivo as both a voltage sensor for EC coupling and a Ca channel.

In summary, a skeletal muscle-specific cDNA has been cloned in the frog. Structurally and functionally, this molecule codes for the main subunit of an L-type Ca2+ channel. This channel activates rapidly, resembling the minor fast component of native ICa, and inactivates in a voltage- and Ca2+-dependent manner, as expected from its truncated C terminus. Its sequence is adequate for skeletal muscle-type EC coupling, although its functionality in this regard remains to be shown. Its similarities and differences, both functional and structural, with other L-type Ca2+ channels, make this molecule an interesting new tool for studies of Ca2+ current and Ca2+ release gating, as well as modulation and gene expression of L-type Ca2+ channels in skeletal muscle.

    ACKNOWLEDGEMENTS

We are grateful to our colleagues Natalia Shirokova, Adom González, and Gonzalo Ferreira for criticism and suggestions.

    FOOTNOTES

* This work was supported by Grant AR43113 from the National Institute of Arthritis and Musculoskeletal and Skin Diseases and a grant-in-aid from the Muscular Dystrophy Association (to E. R.).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

The nucleotide sequence(s) reported in this paper has been submitted to the GenBankTM/EMBL Data Bank with accession number(s) AF037625.

§ Present address: 559 MRB II, Dept. of Clinic Pharmacology, Vanderbilt University Medical Center, 23rd Ave., Nashville, TN 37232-6602. E-mail: Jingsong.zhou{at}mcmail.Vanderbilt.edu.

parallel To whom correspondence should be addressed: Dept. of Molecular Biophysics and Physiology, Rush University, 1750 W. Harrison, Chicago, IL 60612. Tel.: 312-942-3014; Fax: 312-942-8711; E-mail: erios{at}rush.edu.

The abbreviations used are: EC, excitation-contraction; DHP, dihydropyridine; DHPr, dihydropyridine receptor; PKA, cAMP-dependent protein kinase.

2 The replaced segment starts in the middle of IS1 and ends in the middle of IS6. The replacement can be termed a full domain swap, however, because IS1 and IS6 are almost identical in the frog protein and rabbit alpha 1C.

    REFERENCES
Top
Abstract
Introduction
Procedures
Results
Discussion
References

  1. Adams, B., and Tanabe, T. (1997) J. Gen. Physiol. 110, 379-389[Abstract/Free Full Text]
  2. Beam, K. G., Adams, B. A., Niidome, T., Numa, S., and Tanabe, T. (1992) Nature 360, 169-171[CrossRef][Medline] [Order article via Infotrieve]
  3. Rios, E., and Brum, G. (1987) Nature 325, 717-720[CrossRef][Medline] [Order article via Infotrieve]
  4. Tanabe, T., Beam, K. G., Powell, J. A., and Numa, S. (1988) Nature 336, 134-139[CrossRef][Medline] [Order article via Infotrieve]
  5. Tanabe, T., Takeshima, H., Mikami, A., Flockerzi, V., Takahashi, H., Kangawa, K., Kojima, M., Matsuo, H., Hirose, T., and Numa, S. (1987) Nature 328, 313-318[CrossRef][Medline] [Order article via Infotrieve]
  6. Grabner, M., Friedrich, K., Knaus, H. G., Striessnig, J., Scheffauer, F., Staudinger, R., Koch, W. J., Schwartz, A., and Glossmann, H. (1991) Proc. Natl. Acad. Sci. U. S. A. 88, 727-731[Abstract/Free Full Text]
  7. Hogan, K., Powers, P. A., and Gregg, R. G. (1994) Genomics 24, 608-609[CrossRef][Medline] [Order article via Infotrieve]
  8. Tang, S., Mikala, G., Bahinski, A., Yatani, A., Varadi, G., and Schwartz, A. (1993) J. Biol. Chem. 268, 13026-13029[Abstract/Free Full Text]
  9. Tang, S., Yatani, A., Bahinski, A., Mori, Y., and Schwartz, A. (1993) Neuron 11, 1013-1021[CrossRef][Medline] [Order article via Infotrieve]
  10. Ren, D., and Hall, L. M. (1997) J. Biol. Chem. 272, 22393-22396[Abstract/Free Full Text]
  11. Perez-Reyes, E., Kim, H. S., Lacerda, A. E., Horne, W., Wei, X. Y., Rampe, D., Campbell, K. P., Brown, A. M., and Birnbaumer, L. (1989) Nature 340, 233-236[CrossRef][Medline] [Order article via Infotrieve]
  12. Lacerda, A. E., Kim, H. S., Ruth, P., Perez-Reyes, E., Flockerzi, V., Hofmann, F., Birnbaumer, L., and Brown, A. M. (1991) Nature 352, 527-530[CrossRef][Medline] [Order article via Infotrieve]
  13. Nakai, J., Dirksen, R. T., Nguyen, H. T., Pessah, I. N., Beam, K. G., and Allen, P. D. (1996) Nature 380, 72-75[CrossRef][Medline] [Order article via Infotrieve]
  14. Johnson, B. D., Brousal, J. P., Peterson, B. Z., Gallombardo, P. A., Hockerman, G. H., Lai, Y., Scheuer, T., and Catterall, W. A. (1997) J. Neurosci. 17, 1243-1255[Abstract/Free Full Text]
  15. Chomczynski, P., and Sacchi, N. (1987) Anal. Biochem. 162, 156-159[Medline] [Order article via Infotrieve]
  16. Ferreira, G., Yi, J., Rios, E., and Shirokov, R. (1997) J. Gen. Physiol. 109, 449-461[Abstract/Free Full Text]
  17. Sambrook, J, Fritsch, E. F., and Maniatis, T. (1989) Molecular Cloning: A Laboratory Manual, 2nd Ed., Cold Spring Harbor Laboratory, Cold Spring Harbor, NY
  18. Mikami, A., Imoto, K., Tanabe, T., Niidome, T., Mori, Y., Takeshima, H., Narumiya, S., and Numa, S. (1989) Nature 340, 230-233[CrossRef][Medline] [Order article via Infotrieve]
  19. Papazian, D. M., Timpe, L. C., Jan, Y. N., and Jan, L. Y. (1991) Nature 349, 305-310[CrossRef][Medline] [Order article via Infotrieve]
  20. Stuhmer, W., Conti, F., Suzuki, H., Wang, X. D., Noda, M., Yahagi, N., Kubo, H., and Numa, S. (1989) Nature 339, 597-603[CrossRef][Medline] [Order article via Infotrieve]
  21. Garcia, J., Nakai, J., Imoto, K., and Beam, K. G. (1997) Biophys. J. 72, 2515-2523[Abstract/Free Full Text]
  22. Tomaselli, G. F., Backx, P. H., and Marban, E. (1993) Circ. Res. 72, 491-496[Free Full Text]
  23. Yang, J., Ellinor, P. T., Sather, W. A., Zhang, J. F., and Tsien, R. W. (1993) Nature 366, 158-161[CrossRef][Medline] [Order article via Infotrieve]
  24. Tsien, R. W., Lipscombe, D., Madison, D. V., Bley, K. R., and Fox, A. P. (1988) Trends Neurosci. 11, 431-438[CrossRef][Medline] [Order article via Infotrieve]
  25. Peterson, B. Z., Tanada, T. N., and Catterall, W. A. (1996) J. Biol. Chem. 271, 5293-5296[Abstract/Free Full Text]
  26. Armstrong, C. M., Bezanilla, F. M., and Horowicz, P. (1972) Biochim. Biophys. Acta 267, 605-608[Medline] [Order article via Infotrieve]
  27. Endo, M. (1977) Physiol. Rev. 57, 71-108[Free Full Text]
  28. Tanabe, T., Beam, K. G., Adams, B. A., Niidome, T., and Numa, S. (1990) Nature 346, 567-569[CrossRef][Medline] [Order article via Infotrieve]
  29. Garcia, J., Gamboa-Aldeco, R., and Stefani, E. (1990) Pflugers Arch. 417, 114-116[CrossRef][Medline] [Order article via Infotrieve]
  30. Arreola, J., Calvo, J., Garcia, M. C., and Sanchez, J. A. (1987) J. Physiol. 393, 307-330[Abstract/Free Full Text]
  31. Rohrkasten, A., Meyer, H. E., Nastainczyk, W., Sieber, M., and Hofmann, F. (1988) J. Biol. Chem. 263, 15325-15329[Abstract/Free Full Text]
  32. Rotman, E. I., Murphy, B. J., and Catterall, W. A. (1995) J. Biol. Chem. 270, 16371-16377[Abstract/Free Full Text]
  33. Kemp, B. E., and Pearson, R. B. (1990) Trends Biochem. Sci. 15, 342-346[Medline] [Order article via Infotrieve]
  34. Ellis, S. B., Williams, M. E., Ways, N. R., Brenner, R., Sharp, A. H., Leung, A. T., Campbell, K. P., McKenna, E., Koch, W. J., Hui, A., Schwartz, A., and Harpold, M. M. (1988) Science 241, 1661-1664[Abstract/Free Full Text]
  35. Berjukow, S., Doring, F., Froschmayr, M., Grabner, M., Glossmann, H., and Hering, S. (1996) Br. J. Pharmacol. 118, 748-754[Medline] [Order article via Infotrieve]
  36. Cota, G., Nicola Siri, L., and Stefani, E. (1983) J. Physiol. 338, 395-412[Abstract/Free Full Text]
  37. Tanabe, T., Adams, B. A., Numa, S., and Beam, K. G. (1991) Nature 352, 800-803[CrossRef][Medline] [Order article via Infotrieve]
  38. de Leon, M., Wang, Y., Jones, L., Perez-Reyes, E., Wei, X., Soong, T. W., Snutch, T. P., and Yue, D. T. (1995) Science 270, 1502-1506[Abstract/Free Full Text]
  39. Zhou, J., Olcese, R., Qin, N., Noceti, F., Birnbaumer, L., and Stefani, E. (1997) Proc. Natl. Acad. Sci. U. S. A. 94, 2301-2305[Abstract/Free Full Text]
  40. Zong, S., Zhou, J., and Tanabe, T. (1994) Biochem. Biophys. Res. Commun. 201, 1117-1123[CrossRef][Medline] [Order article via Infotrieve]
  41. Cota, G., and Stefani, E. (1986) J. Physiol. 370, 151-163[Abstract/Free Full Text]
  42. Feldmeyer, D., Melzer, W., Pohl, B., and Zollner, P. (1990) J. Physiol. 425, 347-367[Abstract/Free Full Text]
  43. Garcia, J., Avila-Sakar, A. J., and Stefani, E. (1990) Pflugers Arch. 416, 210-212[CrossRef][Medline] [Order article via Infotrieve]
  44. Wang, Z., Grabner, M., Berjukow, S., Savchenko, A., Glossmann, H., and Hering, S. (1995) J. Physiol. 486, 131-137[Medline] [Order article via Infotrieve]
  45. Avila-Sakar, A. J., Cota, G., Gamboa-Aldeco, R., Garcia, J., Huerta, M., Muniz, J., and Stefani, E. (1986) J. Muscle Res. Cell Motil. 7, 291-298[CrossRef][Medline] [Order article via Infotrieve]
  46. De Jongh, K. S., Merrick, D. K., and Catterall, W. A. (1989) Proc. Natl. Acad. Sci. U. S. A. 86, 8585-8589[Abstract/Free Full Text]
  47. Lai, Y., Seagar, M. J., Takahashi, M., and Catterall, W. A. (1990) J. Biol. Chem. 265, 20839-20848[Abstract/Free Full Text]
  48. De Jongh, K. S., Warner, C., Colvin, A. A., and Catterall, W. A. (1991) Proc. Natl. Acad. Sci. U. S. A. 88, 10778-10782[Abstract/Free Full Text]


Copyright © 1998 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike